LYPHOLYTE DIN 02139618
Health Canada record
| Active ingredient(s) | SODIUM ACETATE 2.7 G; POTASSIUM CHLORIDE 2.5 G; SODIUM GLUCONATE 1.1 G; MAGNESIUM ACETATE 860 MG; POTASSIUM ACETATE 690 MG; CALCIUM ACETATE 440 MG |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | ETHICAL |
| Class | Human |
| ATC | B05XA30 COMBINATIONS OF ELECTROLYTES |
| Original market date | 14-Aug-1996 |
| Current status date | 10-Jan-2008 |
| Source | Health Canada DPD |
Establishment licence of the holder
Pharmaceutics International Inc. — licence , not currently licensed, last inspection rating I (2026-02-23).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing SODIUM ACETATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02181746 | SODIUM ACETATE INJECTION USP | OMEGA LABORATORIES LIMITED | Solution | SODIUM ACETATE 328 MG | Marketed |
| 02139529 | SODIUM ACETATE INJECTION, USP | FRESENIUS KABI CANADA LTD | Solution | SODIUM ACETATE 328 MG | Marketed |
| 02247204 | 16.4% SODIUM ACETATE INJECTION, USP | BAXTER CORPORATION | Solution | SODIUM ACETATE 16.4 % | Cancelled Post Market |
| 02366533 | CITRASATE C0125 | CHIEF MEDICAL SUPPLIES LTD | Solution | SODIUM ACETATE 1.11 G; SODIUM CHLORIDE 263 G; CALCIUM CHLORIDE 6.24 G; MAGNESIUM CHLORIDE 2.14 G; DEXTROSE 49.50 G; CITRIC ACID 6.91 G | Dormant |
| 02373807 | H.E.L.P. ACETATE BUFFER PH 4.85 | B. BRAUN AVITUM AG | Solution | SODIUM ACETATE 27.22 G; ACETIC ACID 6.82 G | Dormant |
| 01963910 | HYPERLYTE (MULTI-ELECTROLYTE CONCENTRATE) | B. BRAUN MEDICAL INC | Liquid | SODIUM ACETATE 2.72 G; POTASSIUM CHLORIDE 2.46 G; SODIUM GLUCONATE 1.09 G; MAGNESIUM ACETATE 860 MG; POTASSIUM ACETATE 690 MG; CALCIUM ACETATE 440 MG | Cancelled Post Market |
| 01944940 | LYPHOLYTE MULTI-ELECTROLYTE CONC INJ | LYPHOMED, DIVISION OF FUJISAWA CANADA INC. | Liquid | SODIUM ACETATE 135 MG; POTASSIUM CHLORIDE 125 MG; SODIUM GLUCONATE 55 MG; MAGNESIUM ACETATE 43 MG; POTASSIUM ACETATE 34.5 MG; CALCIUM ACETATE 22 MG | Cancelled Post Market |
| 01944843 | SODIUM ACETATE INJ 328MG/ML USP | LYPHOMED, DIVISION OF FUJISAWA CANADA INC. | Liquid | SODIUM ACETATE 328 MG | Cancelled Post Market |
| 00780642 | SODIUM ACETATE INJ 328MG/ML USP | SABEX INC | Liquid | SODIUM ACETATE 328 MG | Cancelled Post Market |
International API supply for SODIUM ACETATE
9 active FDA Drug Master Files.
Request a quote for LYPHOLYTE